Call for Abstracts

You are strongly encouraged to use the official PowerPoint template for your presentation.

The template contains the congress logo and the appropriate font and layout. Please use a standard 16:9 aspect ratio for your slides.

EA4HP2024_Speaker_PPT-Master_general_format

The 2024 EA4HP lymphoma symposium will provide in depth focus on novel mechanisms in lymphomagenesis with specific sessions dedicated to clonal lymphoid haematopoiesis, epigenetics in lymphomagenesis and lymphoproliferations associated with germline abnormalities.  These will be complemented by a session addressing new frontiers in the treatment of lymphoma and a traditional recent advances session.  The scientific program includes a mixture of Keynote and Topic Lectures supplemented by oral abstract and poster presentations.  Other highlights include the Karl Lennert Lecture, David Mason award and Meet the Professor Sessions.

Abstract submission Subject Headings

• Clonal lymphoid haematopoiesis
• Epigenetics in lymphomagenesis
• Lymphoproliferations associated with germline abnormalities
• New frontiers in the treatment of lymphoma
• Recent Advances

The 2024 EA4HP bone marrow symposium will focus on reactive and therapy induced bone marrow changes linked to systemic infectious and non-infectious disorders, macrophage activation syndromes and hemophagocytic lymphohistiocytosis, myeloid neoplasms with evidence of the additive / cumulative effect of molecular genetic alterations that “pave the way” to a specific disease category, subcategory or entity, and lessons about the organization of the stem-, committed- and precursor-cell bone marrow populations learned from myeloid and lymphoid precursor cell neoplasms and mixed phenotype acute leukemias.

• Reactive and therapy induced bone marrow changes
• Organization of the stem-, committed- and precursor-cell bone marrow populations
• Myeloid and lymphoid precursor cell neoplasms and mixed phenotype acute leukemias
• Molecular genetics of myeloid neoplasms
• Recent advances in myeloid neoplasms

The abstracts will be reviewed and selected by the scientific committee. Notifications will be sent to the authors via email.

Please read the essentials for abstracts carefully as abstracts not prepared correctly, will not be considered for presentation.

• Abstract text is limited to 2,500 characters
• Abstracts must be submitted in English
• Please structure your abstract as follows:
  • Background
  • Principals/Methodology
  • Results
  • Conclusion

1. Two tables and graphics can be used
2. All abstracts must contain original work
3. Please indicate your preferred type of presentation (oral or poster) and choose a topic
4. Please check spelling and grammar carefully. All abstracts will be published as submitted